Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KOSTUK, William J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Fluorescence spectroscopic Analysis of circulating Platelet activation during coronary angioplastyCHRISTOV, Alexander; KOSTUK, William J; JABLONSKY, George et al.Lasers in surgery and medicine. 2001, Vol 28, Num 5, pp 414-426, issn 0196-8092Article

Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease: The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcome (AIM―HIGH) TrialTEO, Koon K; GOLDSTEIN, Larry B; BODEN, William E et al.Stroke (1970). 2013, Vol 44, Num 10, pp 2688-2693, issn 0039-2499, 6 p.Article

Acute cardiovascular responses to leg-press resistance exercise in heart transplant recipientsOLIVER, Doug; PFLUGFELDER, Peter W; MCCARTNEY, Neil et al.International journal of cardiology. 2001, Vol 81, Num 1, pp 61-74, issn 0167-5273Article

A three tiered fluorescence-based system for monitoring activation-related changes in human plateletsCHRISTOV, Alexander; KOSTUK, William J; LUCAS, Alexandra et al.SPIE proceedings series. 2000, pp 167-179, isbn 0-8194-3817-0Conference Paper

Optimal medical therapy with or without PCI for stable coronary diseaseBODEN, William E; O'ROURKE; CHAITMAN, Bernard R et al.The New England journal of medicine. 2007, Vol 356, Num 15, pp 1503-1516, issn 0028-4793, 14 p.Article

Concurrent robotic hybrid revascularization using an enhanced operative suiteKIAII, Bob; MCCLURE, R. Scott; KOSTUK, William J et al.Chest. 2005, Vol 128, Num 6, pp 4046-4048, issn 0012-3692, 3 p.Article

Increased circulating monocyte activation in patients with unstable coronary syndromesZALAI, Christian V; KOLODZIEJCZYK, M. Dean; JABLONSKY, George et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 5, pp 1340-1347, issn 0735-1097Article

Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)GOSSELIN, Gilbert; TEO, Koon K; SPERTUS, John A et al.The American journal of cardiology. 2012, Vol 109, Num 7, pp 954-959, issn 0002-9149, 6 p.Article

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy Observations From the COURAGE TrialJOHN MANCINI, G. B; HARTIGAN, Pamela M; TEO, Koon K et al.Circulation. Cardiovascular interventions. 2011, Vol 4, Num 6, pp 545-552, issn 1941-7640, 8 p.Article

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden : Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear SubstudySHAW, Leslee J; BERMAN, Daniel S; CHAITMAN, Bernard R et al.Circulation (New York, N.Y.). 2008, Vol 117, Num 10, pp 1283-1291, issn 0009-7322, 9 p.Article

Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) TrialMARON, David J; BODEN, William E; DADA, Marcin et al.Journal of the American College of Cardiology. 2011, Vol 58, Num 2, pp 131-137, issn 0735-1097, 7 p.Article

Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)BODEN, William E; O'ROURKE, Robert A; BERMAN, Daniel S et al.The American journal of cardiology. 2009, Vol 104, Num 1, pp 1-4, issn 0002-9149, 4 p.Article

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease: A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) TrialTEO, Koon K; SEDLIS, Steven P; BERMAN, Daniel S et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 14, pp 1303-1308, issn 0735-1097, 6 p.Article

Intensive Multifactorial Intervention for Stable Coronary Artery Disease: Optimal Medical Therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial : Prevention/outcomesMARON, David J; BODEN, William E; HARRIS, Crystal L et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 13, pp 1348-1358, issn 0735-1097, 11 p.Article

Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?CHAITMAN, Bernard R; HARTIGAN, Pamela M; WEINTRAUB, William S et al.Circulation. Cardiovascular quality and outcomes (Print). 2010, Vol 3, Num 5, pp 476-483, issn 1941-7713, 8 p.Article

Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) TrialMARON, David J; SPERTUS, John A; CHAITMAN, Bernard R et al.The American journal of cardiology. 2009, Vol 104, Num 8, pp 1055-1062, issn 0002-9149, 8 p.Article

Simultaneous integrated coronary artery revascularization with long-term angiographic follow-upKIAII, Bob; MCCLURE, R. Scott; ALMOND, David et al.Journal of thoracic and cardiovascular surgery. 2008, Vol 136, Num 3, pp 702-708, issn 0022-5223, 7 p.Article

Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allograftsHADDAD, Michel; PFLUGFELDER, Peter W; GUIRAUDON, Collette et al.The Journal of heart and lung transplantation. 2005, Vol 24, Num 9, pp 1218-1225, issn 1053-2498, 8 p.Article

  • Page / 1